1 Comment

Do you think they could just buy amyris I mean they did it with zymergen and amyris marketcap is 500m which is less than what ginko looses in a quarter?

And you always mention that amyris is like 10 years ahead but I feel that could change soon once a company is so desperate for money work becomes unplesant and if you have a competetor with better conditions things can change quickly.

Thanks for the article :)

Expand full comment